These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17904248)

  • 21. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
    Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
    J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages.
    von Wichert G; Jiang G; Kostic A; De Vos K; Sap J; Sheetz MP
    J Cell Biol; 2003 Apr; 161(1):143-53. PubMed ID: 12682088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical modulation of VLA integrin affinity in human breast cancer cells.
    Pec MK; Artwohl M; Fernández JJ; Souto ML; Alvarez de la Rosa D; Giraldez T; Valenzuela-Fernández A; Díaz-González F
    Exp Cell Res; 2007 Apr; 313(6):1121-34. PubMed ID: 17331499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2.
    von Wichert G; Haimovich B; Feng GS; Sheetz MP
    EMBO J; 2003 Oct; 22(19):5023-35. PubMed ID: 14517241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
    Shih YW; Chien ST; Chen PS; Lee JH; Wu SH; Yin LT
    Cell Biochem Biophys; 2010 Sep; 58(1):31-44. PubMed ID: 20652762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective regulation of integrin--cytoskeleton interactions by the tyrosine kinase Src.
    Felsenfeld DP; Schwartzberg PL; Venegas A; Tse R; Sheetz MP
    Nat Cell Biol; 1999 Aug; 1(4):200-6. PubMed ID: 10559917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells.
    Wang PS; Chou FS; Porchia L; Saji M; Pinzone JJ
    Mol Carcinog; 2008 Dec; 47(12):905-15. PubMed ID: 18314876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Betaig-h3 interacts with alpha3beta1 integrin to promote adhesion and migration of human hepatoma cells.
    Tang J; Wu YM; Zhao P; Jiang JL; Chen ZN
    Exp Biol Med (Maywood); 2009 Jan; 234(1):35-9. PubMed ID: 18997105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of focal adhesion kinase expression correlates with changes in the cytoskeleton but not apoptosis in primary cultures of chick embryo cells.
    Ridyard MS; Sanders EJ
    Cell Biol Int; 2001; 25(3):215-26. PubMed ID: 11352494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.
    Han EK; Mcgonigal T; Wang J; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(6):3899-905. PubMed ID: 15736429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3.
    Li P; Liu F; Sun L; Zhao Z; Ding X; Shang D; Xu Z; Sun C
    Int J Mol Med; 2011 May; 27(5):679-87. PubMed ID: 21347514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha1beta1-integrin engagement to distinct laminin-1 domains orchestrates spreading, migration and survival of neural crest cells through independent signaling pathways.
    Desban N; Lissitzky JC; Rousselle P; Duband JL
    J Cell Sci; 2006 Aug; 119(Pt 15):3206-18. PubMed ID: 16847051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
    Yang P; Li Z; Fu R; Wu H; Li Z
    Cell Signal; 2014 Sep; 26(9):1853-62. PubMed ID: 24686087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of focal adhesion kinase through an interaction with β4 integrin contributes to tumorigenicity of colon cancer.
    Tai YL; Lai IR; Peng YJ; Ding ST; Shen TL
    FEBS Lett; 2016 Jun; 590(12):1826-37. PubMed ID: 27178753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs.
    Shibue T; Weinberg RA
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10290-5. PubMed ID: 19502425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages.
    Choquet D; Felsenfeld DP; Sheetz MP
    Cell; 1997 Jan; 88(1):39-48. PubMed ID: 9019403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decoding Cytoskeleton-Anchored and Non-Anchored Receptors from Single-Cell Adhesion Force Data.
    Sariisik E; Popov C; Müller JP; Docheva D; Clausen-Schaumann H; Benoit M
    Biophys J; 2015 Oct; 109(7):1330-3. PubMed ID: 26445433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion.
    Lin YN; Bhuwania R; Gromova K; Failla AV; Lange T; Riecken K; Linder S; Kneussel M; Izbicki JR; Windhorst S
    Oncotarget; 2015 Jul; 6(21):18577-89. PubMed ID: 26124177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.